Skip to content
10-K

Annual Report

Protara Therapeutics, Inc. TARA

0001213900-26-025433

← back to feed
Filed
Mar 10, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 5, 2026 54.08M sh
Shares Diluted FY 2025 · Dec 31, 2025 42.84M sh
Shares Diluted FY 2025 · Dec 31, 2024 20.59M sh
Capex FY 2025 · Dec 31, 2025 $94K
Capex FY 2025 · Dec 31, 2024 $63K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$56.37M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$35.81M
Cash And Equivalents FY 2025 · Dec 31, 2025 $49.66M
Cash And Equivalents FY 2025 · Dec 31, 2024 $162.8M
Stockholders Equity FY 2025 · Dec 31, 2025 $196.41M
Stockholders Equity FY 2025 · Dec 31, 2024 $167.13M
Stockholders Equity FY 2025 · Dec 31, 2023 $68.32M
Current Liabilities FY 2025 · Dec 31, 2025 $10.94M
Current Liabilities FY 2025 · Dec 31, 2024 $10.96M
Total Liabilities FY 2025 · Dec 31, 2025 $13.06M
Total Liabilities FY 2025 · Dec 31, 2024 $14.32M
Current Assets FY 2025 · Dec 31, 2025 $159.5M
Current Assets FY 2025 · Dec 31, 2024 $172.16M
Total Assets FY 2025 · Dec 31, 2025 $209.47M
Total Assets FY 2025 · Dec 31, 2024 $181.45M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.34
Eps Diluted FY 2025 · Dec 31, 2024 −$2.17
Eps Basic FY 2025 · Dec 31, 2025 −$1.34
Eps Basic FY 2025 · Dec 31, 2024 −$2.17
Sga Expense FY 2025 · Dec 31, 2025 $21.92M
Sga Expense FY 2025 · Dec 31, 2024 $17.45M
Rd Expense FY 2025 · Dec 31, 2025 $42.63M
Rd Expense FY 2025 · Dec 31, 2024 $31.7M
Net Income FY 2025 · Dec 31, 2025 −$57.44M
Net Income FY 2025 · Dec 31, 2024 −$44.6M
Operating Income FY 2025 · Dec 31, 2025 −$64.55M
Operating Income FY 2025 · Dec 31, 2024 −$49.15M